New Leadership at Howard Brown Health: Dr. Travis Gayles Appointed CEO
February 4, 2025 - 19:23
In a significant development for Howard Brown Health, Dr. Travis Gayles has been appointed as the new Chief Executive Officer following a comprehensive nationwide search. This leadership transition is particularly noteworthy as it coincides with the organization’s 50th anniversary, marking half a century of dedicated service to the community.
Dr. Gayles brings a wealth of experience in public health and healthcare administration to his new role. His background includes extensive work in health equity and innovative healthcare solutions, making him a fitting choice to guide the organization into its next chapter. As Howard Brown Health continues to expand its services and outreach, Dr. Gayles is expected to play a pivotal role in addressing the evolving healthcare needs of the diverse populations it serves.
The organization has expressed enthusiasm about Dr. Gayles' vision and leadership, anticipating that his expertise will help propel Howard Brown Health forward as it embraces new challenges and opportunities in the healthcare landscape.
MORE NEWS
July 2, 2026 - 04:03
VA health secretary quits less than a year into tenureJohn Bartrum, the official who oversaw the Veterans Health Administration`s troubled rollout of a new electronic health records system, has resigned from his post less than a year after taking the...
July 1, 2026 - 08:37
Anglia Ruskin mental health nursing course under reviewThe Nursing and Midwifery Council has called for an `extraordinary review` of the mental health nursing course at Anglia Ruskin University. The regulatory body`s decision comes amid concerns over...
June 30, 2026 - 22:44
Politics: High Cost Of Healthcare And The Political FalloutAmericans are feeling the squeeze of rising healthcare expenses like never before. For the first time in five years, fewer than half of U.S. adults say they can consistently afford medical care,...
June 30, 2026 - 15:13
Top GLP-1 prescription indications include sleep apnea, depression and kidney disease, study findsA new analysis of insurance claims data reveals that prescriptions for GLP-1 medications are increasingly being approved for conditions far beyond their original use for diabetes and weight loss....